Solid-phase syntheses of peptoids using Fmoc-protected N-substituted glycines: The synthesis of (retro)peptoids of leu-enkephalin and substance P

Chemistry - A European Journal

Volumn 4, Issue 8, 1998, Pages 1570-1580

  Kruijtzer, John A W ^a   Hofmeyer, Lovina J F ^a   Heerma, Wigger ^b   Versluis, Cornelis ^b   Liskamp, Rob M J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Mass spectrometry; Peptidomimetics; Peptoids; Solid phase synthesis; Substance P

Indexed keywords

GLYCINE; LEUCINE ENKEPHALIN; PEPTOID; RETROPEPTOID; SUBSTANCE P;

EID: 0031875776     PISSN: 09476539     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3765(19980807)4:8<1570::AID-CHEM1570>3.0.CO;2-2     Document Type: Article

References (46)

1. A. Giannis, T. Kolter, Angew. Chem. 1993, 105, 1303-1326; Angew. Chem. Int. Ed. Engl. 1993, 32, 1244-1267.
2. A. Giannis, T. Kolter, Angew. Chem. 1993, 105, 1303-1326; Angew. Chem. Int. Ed. Engl. 1993, 32, 1244-1267.
3. R. J. Simon, R. S. Kania, R. N. Zuckermann, V. D. Huebner, D. A. Jewell, S. Banville, S. Ng, L. Wang, S. Rosenberg, C. K. Marlowe, D. C. Spellmeyer, R. Tan, A. D. Frankel, D. V. Santi, F. E. Cohen, P. A. Bartlett, Proc. Natl. Acad. Sci USA 1992, 89, 9367-9371.
4. H. Kessler, Angew. Chem. 1993, 105, 512-513; Angew. Chem. Int. Ed. Engl. 1993, 32, 543-544.
5. H. Kessler, Angew. Chem. 1993, 105, 512-513; Angew. Chem. Int. Ed. Engl. 1993, 32, 543-544.
6. a) R. N. Zuckermann, J. M. Kerr, S. B. H. Kent, W. H. Moos, J. Am. Chem. Soc. 1992, 114, 10646-10647;
7. b) R. N. Zuckermann, E. J. Martin, D. C. Spellmeyer, G. B. Stauber, K. R. Shoemaker, J. M. Kerr, G. M. Figliozzi, D. A. Goff, M. A. Siani, R. J. Simon, S. C. Banville, E. G. Brown, L. Wang, L. S. Richter, W. H. Moos, J. Med. Chem. 1994, 37, 2678-2685;
8. c) R. J. Simon, E. J. Martin, S. M. Miller, R. N. Zuckermann, J. M. Blaney, W. H. Moos in Techniques in Protein Chemistry V (Ed.: J. W. Crabb). Academic Press, San Diego, CA, 1994, 533-539;
9. d) J. A. Gibbons, A. A. Hancock, C. R. Vitt, S. Knepper, S. A. Buckner, M. E. Brune, I. Milicic, J. F. Kerwin Jr., L. S. Richter, E. W. Taylor, K. L. Spear, R. N. Zuckermann, D. C. Spellmeyer, R. A. Braeckman, W. H. Moos, J. Pharmacol. Exp. Ther. 1996, 277, 885-899.
10. a) J. A. W. Kruijtzer, R. M. J. Liskamp, Tetrahedron Lett. 1995, 36, 6969-6972;
11. b) J. A. W. Kruijtzer, Synthesis of Peptoid Peptidomimetics, Thesis, Utrecht University, The Netherlands, 1996.
12. E. K. Bradley, J. Magn. Reson. B 1996, 110, 195-197.
13. a) S. M. Miller, R. J. Simon, S. Ng, R. N. Zuckermann, J. M. Kerr, W. H. Moos, Bioorg. Med. Chem. Lett. 1994, 4, 2657-2662;
14. b) S. M. Miller, R. J. Simon, S. Ng, R. N. Zuckermann, J. M. Kerr, W. H. Moos, Drug Dev. Res. 1995, 35, 20-30.
15. a) W. Heerma, C. Versluis, C. G. de Koster, J. A. W. Kruijtzer, I. Zigrovic, R. M. J. Liskamp, Rapid Commun. Mass Spectrom. 1996, 10, 459-464;
16. b) W. Heerma, J. P. J. L. Boon, C. Versluis, J. A. W. Kruijtzer, L. J. F. Hofmeyer, R. M. J. Liskamp, J. Mass Spectrom. 1997, 32, 697-704;
17. c) W. Heerma, J.-P. Boon, C. Versluis, Tandem Mass Spectra of Peptides and Peptoids: Similarities and Differences, Proc. 14th IMSC, Finland, 1997, in press.
18. 1 Antagonists, Thesis, Utrecht University, The Netherlands. 1997.
19. a) E. Atherton, R. C. Sheppard, Solid-Phase Peptide Synthesis, IRL, Oxford, England, 1989;
20. b) G. B. Fields, R. L. Noble, Int. J. Pept. Protein Res. 1990, 35, 161-214.
21. a) J. Hughes, T. W. Smith, H. W. Kosterlitz, L. A. Fothergill, B. A. Morgan, H. R. Morris, Nature 1975, 258, 577-579;
22. b) A. L. Lomize, I. D. Pogozheva, H. I. Mosberg, Biopolymers 1996, 38, 221-234.
23. a) K. J. Watling, S. Guard, Neurotransmissions 1992, VIII, 1-6;
24. b) N. Frossard, C. Advenier, Life Sci. 1991, 49, 1941-1953;
25. c) J. E. Krause, Y. Takeda, A. D. Hershey, J. Invest. Dermatol 1992, 98 suppl., 2S-7S;
26. d) J. A. Lowe III, Drugs Future 1992, 17, 1115-1121;
27. e) J. M. Lundberg, Pharmacol Rev. 1996, 48, 113-178.
28. The nomenclature is according to the proposed nomenclature by Simon et al. (ref. [2]). For the one letter code of amino acids, we have proposed the prefix n; thus for example nY, nF, and nL; see ref. [8a].
29. G. I. Tesser, I. C. Balvert-Geers, Int. J. Pept. Protein Res. 1975, 7, 295-305.
30. P. B. W. Ten Kortenaar, B. G. Van Dijk, J. M. Peeters, B. J. Raaben, P. J. H. M. Adams, G. I. Tesser, Int. J. Pept. Protein Res. 1986, 27, 398-400.
31. A. Amstrong, I. Brackenridge, R. F. W. Jackson, J. M. Kirk, Tetrahedron Lett. 1988, 29, 2483-2486.
32. a) H. Rink, Tetrahedron Lett. 1987, 28, 3787-3790;
33. b) M. S. Bernatowicz, S. B. Daniels, H. Köster, Tetrahedron Lett. 1989, 30, 4645-4648.
34. It was found that intramolecular aminolysis, that is, diketopiperazine formation was a serious by-reaction of a dipeptoid connected to TentaGel® SOH by an ester linkage. The use of Rink amide resin (TentalGel® S RAM), for the preparation of (peptoid) amides, entirely circumvented the problem of diketopiperazine formation.
35. a) Y. Wu, G. R. Matsueda, M. Bernatowicz, Synth. Commun. 1993, 23, 3055-3060;
36. b) M. Bernatowicz, Y. Wu, G. R. Matsueda, Tetrahedron Lett. 1993, 34, 3389-3392.
37. a) This protection does appear to be sufficient to mask the nucleophilicity of the guanidino function. Ornithine formation through acylation of the unprotected ω-nitrogen during coupling and subsequent intramolecular decomposition during deprotection is completely avoided;
38. b) A. S. Verdini, P. Lucietto, G. Fossati, C. Giordani, Tetrahedron Lett. 1992, 33, 6541-6542.
39. 3. The resulting 2-(methylthio)ethylamine was purified by vacuum distillation, b.p. 56-60°C/20 mmHg.
40. The peptide was acetylated to facilitate purification.
41. J. F. Westra-de Vlieger, L. J. F. Hofmeyer, J. A. W. Kruijtzer, W. Gommeren, J. Leysen, D. van Heuven-Nolsen, J. Wilting, F. P. Nijkamp, R. M. J. Liskamp, Biochem. Pharmacol., submitted.
42. E. Von Arx, M. Faupel, M. Bruggen, J. Chromatogr. 1976, 120, 224-228.
43. For storage, the hydrochloride salt was prepared by dissolving the ester in ether followed by precipitation with a saturated solution of HCl in ether.
44. P. Sieber, Tetrahedron Lett. 1987, 28, 6147-6150.
45. Applied Biosystems Model 433A Peptide Synthesizer User's Manual June 1993, Version 1.0.
46. Applied Biosystems Research News June 1993, Mode 433A Peptide Synthesizer, 1-12.